ATE143261T1 - Zusammensetzung zur behandlung entzündlicher darmerkrankungen - Google Patents

Zusammensetzung zur behandlung entzündlicher darmerkrankungen

Info

Publication number
ATE143261T1
ATE143261T1 AT91900102T AT91900102T ATE143261T1 AT E143261 T1 ATE143261 T1 AT E143261T1 AT 91900102 T AT91900102 T AT 91900102T AT 91900102 T AT91900102 T AT 91900102T AT E143261 T1 ATE143261 T1 AT E143261T1
Authority
AT
Austria
Prior art keywords
inflammatory bowel
treatment
composition
bowel disease
fatty acids
Prior art date
Application number
AT91900102T
Other languages
English (en)
Inventor
Richard I Breuer
Original Assignee
Richard I Breuer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard I Breuer filed Critical Richard I Breuer
Application granted granted Critical
Publication of ATE143261T1 publication Critical patent/ATE143261T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91900102T 1989-11-16 1990-11-15 Zusammensetzung zur behandlung entzündlicher darmerkrankungen ATE143261T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/438,297 US5039703A (en) 1989-11-16 1989-11-16 Method for treating inflammatory bowel disorders

Publications (1)

Publication Number Publication Date
ATE143261T1 true ATE143261T1 (de) 1996-10-15

Family

ID=23740078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900102T ATE143261T1 (de) 1989-11-16 1990-11-15 Zusammensetzung zur behandlung entzündlicher darmerkrankungen

Country Status (11)

Country Link
US (1) US5039703A (de)
EP (1) EP0502925B1 (de)
AT (1) ATE143261T1 (de)
AU (2) AU6681790A (de)
CA (1) CA2071215C (de)
DE (1) DE69028712T2 (de)
DK (1) DK0502925T3 (de)
ES (1) ES2093695T3 (de)
GR (1) GR3021760T3 (de)
IL (1) IL96365A (de)
WO (1) WO1991007176A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
WO1995011699A1 (en) * 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
EP0730447B1 (de) * 1993-11-17 2002-02-20 Commonwealth Scientific And Industrial Research Organisation Fettsäure-abgabesystem
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
AUPO763197A0 (en) 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
WO1999040883A2 (en) * 1998-02-11 1999-08-19 Faller Douglas V Compositions and methods for the treatment of cystic fibrosis
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
JP6113954B2 (ja) * 2008-10-31 2017-04-12 リピッド ファーマシューティカルズ イーエイチエフ． 医薬として使用するための脂肪酸
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
JP4620169B1 (ja) * 2010-01-28 2011-01-26 株式会社三和化学研究所 有機酸重合体を有効成分とするクローン病の予防又は治療剤
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
ES2673276T3 (es) 2013-03-14 2018-06-21 University Of Ottawa Métodos para el diagnóstico y el tratamiento de la enfermedad inflamatoria intestinal
EP3201622A4 (de) * 2014-10-03 2018-05-30 The University of Ottawa Marker für entzündliche darmerkrankung
WO2016210384A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
JP7158104B2 (ja) 2016-07-15 2022-10-21 ビラクタ セラピューティクス，インク． Ｎｋ細胞ベースの療法で使用するためのｈｄａｃ阻害剤
US20190167615A1 (en) * 2016-08-10 2019-06-06 Monash University Metabolites for treatment and prevention of autoimmune disease
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
AU2020283590A1 (en) 2019-05-31 2022-01-20 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors
WO2022144897A1 (en) * 2020-12-31 2022-07-07 Cannamore Biotechs Ltd. A composition for use in the treatment of rectal and/or intestinal inflammation
CN116212027A (zh) * 2023-02-28 2023-06-06 西湖大学 一种调控Treg细胞内铁水平的试剂的用途

Also Published As

Publication number Publication date
DK0502925T3 (da) 1996-12-23
US5039703A (en) 1991-08-13
CA2071215A1 (en) 1991-05-17
CA2071215C (en) 1997-02-04
EP0502925A4 (en) 1992-12-16
WO1991007176A1 (en) 1991-05-30
AU664492B2 (en) 1995-11-16
DE69028712D1 (de) 1996-10-31
IL96365A0 (en) 1991-08-16
AU6681790A (en) 1991-05-23
DE69028712T2 (de) 1997-03-20
IL96365A (en) 1995-06-29
AU5051693A (en) 1994-01-13
EP0502925A1 (de) 1992-09-16
ES2093695T3 (es) 1997-01-01
EP0502925B1 (de) 1996-09-25
GR3021760T3 (en) 1997-02-28

Similar Documents

Publication Publication Date Title
ATE143261T1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
ATE17079T1 (de) Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE156704T1 (de) Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
DE69433713D1 (de) Für die behandlung neurologischer erkrankungen nützliche methoden und pharmazeutische zusammensetzungen
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
DE69327582D1 (de) Methoden zur Behandlung von Interleukin- 1 und - Tumor - Nekrose - Faktor - verursachten Krankheiten
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
ATE99171T1 (de) Praeparate zur behandlung von beschwerden der wurzelhaut der zaehne.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ATE133859T1 (de) Pharmazeutische zubereitungen mit verzögerter freisetzung zur behandlung periodontaler erkrankungen
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
EP0270690A4 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
DE3684904D1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
FR2619713B1 (fr) Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2614203B1 (fr) Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
CA2111417C (en) Composition for treating skin diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee